Search & Analyze
Popular Searches
Eris Lifesciences Ltd.
Healthcare₹1,395.151.76%
24 Jul, 4:01 PM
CMP₹1,395.15
Mkt Cap₹19.33K Cr
P/E31.21
P/B4.95
ROE13.81%
52W High₹1,887.65
52W Low₹1,237.90
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
31.21
P/B Ratio
4.95
EV/EBITDA
19.13
Price/Sales
6.21
Dividend Yield (%)
0.52
EPS (TTM ₹)
44.71
Book Value (₹)
281.62
ROE (%)
13.81
ROCE (%)
13.59
ROA (%)
5.48
EBITDA Margin (%)
34.22
Net Profit Margin (%)
12.61
Debt/Equity
0.85
Current Ratio
0.89
Interest Coverage
3.11
Asset Turnover
0.43
Working Capital/Sales
-18.77
Core EBITDA Growth (%)
48.22
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 12118.63 | 13470.43 | 16851.49 | 2009.15 | 2893.64 |
| Net Sales | 12118.63 | 13470.43 | 16851.49 | 2009.15 | 2893.64 |
| Total Income | 12205.71 | 13731.37 | 16963.02 | 2032.97 | 2912 |
| Total Expenditure | 7811.14 | 8620.15 | 11484.03 | 1334.32 | 1876.44 |
| Operating Profit | 4394.57 | 5111.22 | 5478.99 | 698.65 | 1035.56 |
| Depreciation | 429.85 | 647.05 | 1170.88 | 182.51 | 315.46 |
| Exceptional Items | — | — | — | — | — |
| Profit Before Tax | 3944.97 | 4421.98 | 4046.43 | 431.34 | 488.87 |
| Tax | 393.62 | 364.09 | 304.83 | 34.22 | 114.2 |
| Profit After Tax (PAT) | 3551.35 | 4057.89 | 3741.6 | 397.12 | 374.67 |
| EPS (₹) | 26.16 | 29.89 | 28.1 | 28.82 | 25.85 |
| Dividend Payout % | 550 | 601 | 735 | — | 735 |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 135.78 | 135.93 | 135.99 | 13.6 | 13.62 |
| Reserves | 15588.69 | 18928.22 | 21795.87 | 2567.56 | 2830.65 |
| Shareholders Funds | 15764.21 | 19083.11 | 21959.88 | 2586.18 | 2854.36 |
| Total Debt | 0.1 | 450.11 | 8300.16 | 2735.27 | 2421.66 |
| Total Liabilities | 17028.07 | 21127.41 | 34718.84 | 6810.4 | 6862.28 |
| Total Assets | 17028.07 | 21127.41 | 34718.84 | 6810.4 | 6862.28 |
| Book Value / Share | 115.8084 | 140.2498 | 161.2755 | 189.7912 | 208.8304 |
| Assets | 17028.07 | 21127.41 | 34718.84 | 6810.4 | 6862.28 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 3753.61 | 3782.64 | 2917.38 | 486.01 | 1065.01 |
| Investing Activities | -3233.58 | -3196.1 | -9821.01 | -1854.52 | -79.97 |
| Financing Activities | -823.95 | -446.99 | 6880.25 | 1379.68 | -881.32 |
| Net Cash Flow | -303.92 | 139.55 | -23.38 | 11.17 | 103.72 |
ERIS
₹1,395.15
+1.76%